Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia

Design, synthesis and biological evaluation of 6-(nitroimidazole-1H-alkyloxyl)-4-anilinoquinazolines as efficient EGFR inhibitors exerting cytotoxic effects both under normoxia and hypoxia

(2015) Weiyan Cheng et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Design, Synthesis, and Preliminary Biological Evaluation of 6-O-Glucose–Azomycin Adducts for Diagnosis and Therapy of Hypoxic Tumors

(2012) Piyush Kumar et al.   JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and Characterization of Nitroimidazole Derivatives for68Ga-Labeling and Testing in Tumor Xenografted Mice

(2010) Lathika Hoigebazar et al.   JOURNAL OF MEDICINAL CHEMISTRY

Kinetics and Mechanism ofN-Boc Cleavage: Evidence of a Second-Order Dependence upon Acid Concentration

(2010) Ian W. Ashworth et al.   JOURNAL OF ORGANIC CHEMISTRY

Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs

(2008) Jian-Xin Duan et al.   JOURNAL OF MEDICINAL CHEMISTRY

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

(2008) C.-H. Yun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA